Hikari Tsushin’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.7M Sell
83,101
-18,342
-18% -$4.7M 1.46% 9
2026
Q2
$25.5M Sell
101,443
-3,520
-3% -$757K 1.69% 7
2026
Q1
$22.8M Hold
104,963
– – 1.57% 9
2025
Q4
$24M Hold
104,963
– – 1.56% 9
2025
Q3
$24.3M Hold
104,963
– – 1.63% 9
2025
Q2
$19.5M Hold
104,963
– – 1.37% 10
2025
Q1
$22M Hold
104,963
– – 1.47% 10
2024
Q4
$18.7M Hold
104,963
– – 1.35% 10
2024
Q3
$20.7M Hold
104,963
– – 1.47% 10
2024
Q2
$18M Hold
104,963
– – 1.39% 10
2024
Q1
$19.1M Hold
104,963
– – 1.52% 9
2023
Q4
$16.3M Hold
104,963
– – 1.49% 9
2023
Q3
$15.6M Sell
104,963
-5,114
-5% -$751K 1.52% 9
2023
Q2
$14.8M Hold
110,077
– – 1.42% 9
2023
Q1
$17.5M Hold
110,077
– – 1.83% 7
2022
Q4
$17.8M Hold
110,077
– – 1.89% 8
2022
Q3
$14.8M Hold
110,077
– – 1.8% 9
2022
Q2
$16.9M Hold
110,077
– – 2.05% 8
2022
Q1
$17.8M Hold
110,077
– – 1.79% 9
2021
Q4
$14.9M Buy
+110,077
New +$13M 1.63% 11
2021
Q2
$12.6M Buy
112,119
+63,599
+131% +$7.16M 1.55% 12
2021
Q1
$5.25M Buy
48,520
+39,240
+423% +$4.2M 0.71% 20
2020
Q4
$994K Buy
+9,280
New +$892K 0.15% 32
2016
Q4
– Sell
-59,550
Closed -$3.76M – 28
2016
Q3
$3.76M Hold
59,550
– – 0.99% 17
2016
Q2
$3.69M Hold
59,550
– – 0.91% 18
2016
Q1
$3.4M Hold
59,550
– – 0.8% 21
2015
Q4
$3.53M Hold
59,550
– – 0.91% 17
2015
Q3
$3.24M Sell
59,550
-6,617
-10% -$431K 0.86% 17
2015
Q2
$4.45M Sell
66,167
-3,260
-5% -$213K 0.97% 18
2015
Q1
$4.06M Sell
69,427
-30,073
-30% -$1.82M 0.81% 20
2014
Q4
$6.51M Sell
99,500
-6,500
-6% -$410K 1.2% 20
2014
Q3
$6.12M Sell
106,000
-21,100
-17% -$1.17M 1.14% 22
2014
Q2
$7.17M Hold
127,100
– – 1.13% 24
2014
Q1
$6.53M Hold
127,100
– – 1.06% 23
2013
Q4
$6.71M Hold
127,100
– – 1.14% 22
2013
Q3
$5.68M Hold
127,100
– – 1.08% 19
2013
Q2
$5.25M Buy
+127,100
New +$5.56M 1.2% 20

Other funds holding ABBV

Hikari Tsushin's ABBV Position: Q3 2026 in Review

Hikari Tsushin reduced its AbbVie (ABBV) stake by 18% in Q3 2026, selling an estimated $4.7M and leaving 83,101 shares worth $21.7M. The position accounts for 1.46% of the portfolio, ranked #9.

Hikari Tsushin first reported a position in ABBV in Q2 2013 and has held it in 37 quarters since. The position peaked at $25.5M in Q2 2026. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Hikari Tsushin held 83,101 shares of AbbVie worth $21.7M as of Q3 2026.
  • Hikari Tsushin sold 18,342 AbbVie shares in Q3 2026, an estimated $4.7M.
  • AbbVie made up 1.46% of Hikari Tsushin's portfolio in Q3 2026, its #9 holding.
  • Hikari Tsushin first reported a position in AbbVie in Q2 2013 and has held it in 37 quarters since.
  • Hikari Tsushin's AbbVie position peaked at $25.5M in Q2 2026.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Hikari Tsushin's 13F filing for Q3 2026, filed 12 Nov 2026.